We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Publishes Guidances on Amendments for Tentative ANDAs, CRL Responses
FDA Publishes Guidances on Amendments for Tentative ANDAs, CRL Responses
The FDA has issued two guidances to help generic drug applicants through the abbreviated new drug application (ANDA) process, including a final guidance on the preferred timing and content for changes to tentatively approved applications.